Pretomanid development and its clinical roles in treating tuberculosis
journal contribution
posted on 2025-07-07, 05:55 authored by G Fekadu, T Tolossa, E Turi, F Bekele, G FetensaPretomanid development and its clinical roles in treating tuberculosis
History
Related Materials
- 1.
Location
Amsterdam, The NetherlandsOpen access
- Yes
Language
engPublication classification
C1 Refereed article in a scholarly journalJournal
Journal of Global Antimicrobial ResistanceVolume
31Pagination
175-184ISSN
2213-7165eISSN
2213-7173Publisher
ElsevierUsage metrics
Categories
Keywords
Clinical trialDIAGNOSISDrug-resistant tuberculosisDRUG-RESISTANT TUBERCULOSISDrug-susceptible tuberculosisEARLY BACTERICIDAL ACTIVITYInfectious DiseasesLife Sciences & BiomedicineMULTIDRUG-RESISTANTMycobacterium tuberculosisMYCOBACTERIUM-TUBERCULOSISNovel drugPA-824PHARMACOKINETICSPharmacology & PharmacyPretomanidPYRAZINAMIDERANDOMIZED-TRIALScience & TechnologyTB
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC